News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Hi-Tech Pharmacal Reports Sales of $40.4 Million and EPS of $0.67 for the Quarter Ended July 31, 2010
September 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the Company’s fiscal first quarter ended July 31, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Drug pricing
With MFN now embedded in pharma, execs see little impact from Democrats’ blue wave
November 4, 2026
·
4 min read
·
Annalee Armstrong
Weight loss
Novo, Lilly battle for oral GLP-1 dominance with data tit for tat
November 4, 2026
·
3 min read
·
Annalee Armstrong
Vaccines
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
November 4, 2026
·
1 min read
·
Annalee Armstrong
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst
